Search
for
Sort by
Research 151–180 of 1000+
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Androgenetic alopecia; drug safety and therapeutic strategies
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Comprehension Testing for OTC Drug Labels: Goals, Methods, Target Population, and Testing Environment
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Techniques for the discovery and evaluation of drugs against alopecia
- Novel causes of drug-induced occupational asthma
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Hair Loss Effects and Surgical/Drug Treatments for the Alopecias
- Original article / Article original Counterfeit drugs and pharmaceutical preparations seized from the black market among bodybuilders Médicaments de contrefaçon et préparations pharmaceutiques saisis sur le marché noir parmi les bodybuilders
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Medication Repurposing: New Uses for Old Drugs
- The PDGF/PDGFR pathway as a drug target
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model
- Geometric classification of scalp hair for valid drug testing, 6 more reliable than 8 hair curl groups
- Oil Body-Bound Oleosin-rhFGF-10: A Novel Drug Delivery System that Improves Skin Penetration to Accelerate Wound Healing and Hair Growth in Mice
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- In silico investigation of possible multi-target drugs against Glutamate S-transferase and prolyl tRNA synthetase in Onchocerca volvulus
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Effect of Rubbing on the Distribution of Topically Applied Drugs into the Hair Follicles
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms